# Postpartum Evaluation of Nifedipine and Enalapril for Hypertension

Study · id `cardio:ct-nct07023003` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07023003](<https://clinicaltrials.gov/study/NCT07023003>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07023003

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 850 participants.

## Technical summary

Registry record NCT07023003. Randomized; no masking; primary purpose treatment. Start 2025-07-11 (actual); primary completion 2028-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 850 participants (planned count; ClinicalTrials.gov record NCT07023003, source copy `cardio:ctgov-nct07023003-2025-10-22`, retrieved 2026-10-26)
- Started: 2025-07-11 (actual) (ClinicalTrials.gov record NCT07023003, source copy `cardio:ctgov-nct07023003-2025-10-22`, retrieved 2026-10-26)
- Primary completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT07023003, source copy `cardio:ctgov-nct07023003-2025-10-22`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07023003, source copy `cardio:ctgov-nct07023003-2025-10-22`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07023003, source copy `cardio:ctgov-nct07023003-2025-10-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07023003-2025-10-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Postpartum Evaluation of Nifedipine and Enalapril for Hypertension
- Acronym: PEACE
- Condition: Hypertension in Pregnancy
- Intervention (Drug): Enalapril 10mg QD
- Intervention (Drug): Nifedipine 30mg XL BID
- Lead sponsor: Nebraska Methodist Health System
- Lead sponsor class: OTHER
- Collaborator: Methodist Hospital Foundation
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: cf59d7b30755bb7413e8cf2df3eda2364638a6dae7e5e349322a222ad6da0648
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
